Skip to content
Quant500 - Quantitative Analysis
Search ticker or company...
ES | EN

Company Profile: Henry Schein, Inc. (HSIC)

HSIC insider trades (13 months) →

$82.50 −4.76% vs. previous close · Market cap $9.19B

Today's multi-factor rank: 90 of 461 · see the ranking

Momentum
6.6/10
Value
5.9/10
Growth
4.9/10
Quality
4.2/10
Multifactor
5.4/10

Market and Valuation

Price & Market

Prev Close Price:$86.62
Open:$82.37
Day's Low:$81.05
Day's High:$86.87
Bid / Ask:-
Market Cap:9.19B
Enterprise Value:14.88B

52-Week Range

52-Week Low:$68.00
52-Week High:$92.18
Current position in 52-week range
52w Low-52w High
50-Day Avg:$86.49
200-Day Avg:$81.10

Volume

Volume Today:4,417,634
Avg Volume (3m):1,171,628
Avg Volume (10d):1,261,160
52-Week Change:+20.96%
vs S&P 500, 52 weeks:-
Beta:0.86

Valuation Multiples

P/E (trailing):22.60

Diluted EPS for the last 12 months: the four quarters ended Sep 26, 2026, from the accounts filed with the SEC on Nov 3, 2026. The P/E is the price divided by that EPS.

P/E (forward):13.77
PEG Ratio:1.73
Price / Book:2.92
Price / Sales (TTM):0.68
EV / Revenue:1.09
EV / EBITDA:13.77

Dividends

Current yield:-
Annual Dividend Rate:-
Dividend Trailing:$0.00
Yield Trailing:0.00%
5-Year Avg Yield:-
Payout Ratio:0.00%
Last Ex-Dividend Date:-

Valuation Context

P/E vs sector (indicative)

Most Recent Quarter:-
Fiscal Year (Next):-

Loading historical OHLCV database...

Financial Statements TTM (Trailing 12 Months)

Income Statement

Total Revenue (TTM):13.60B
Gross Profit:4.26B
EBITDA:1.08B
Net Income (TTM):403.00M
Rev Growth (YoY):+6.70%
Earnings Growth (YoY):+17.10%
Quarterly earnings growth (YoY):+9.30%

Margins

Gross Margin:-
EBITDA Margin:-
Operating Margin:-
Net Margin:-

Per Share

EPS Trailing (TTM):$3.65

Diluted EPS for the last 12 months: the four quarters ended Sep 26, 2026, from the accounts filed with the SEC on Nov 3, 2026. The P/E is the price divided by that EPS.

EPS Forward (Est.):$5.99
Revenue Per Share:$116.77
Cash Per Share:-
Book Value:$28.21
Last Dividend:-
Ex-Dividend Date:-
Last Split:-

Balance Sheet & Liquidity

Total cash:157.00M
Total Debt:3.81B
Net Debt (Debt - Cash):3.66B
Debt / Equity:80.73%
Current Ratio:1.32
Quick Ratio:0.55

Cash Flows

Operating Cash Flow:700.00M
Free Cash Flow (FCF):446.00M
FCF Yield (FCF / Market Cap):-
Enterprise Value:14.88B
EV / Revenue:1.09
EV / EBITDA:13.77

Profitability

ROE (Return on Equity):8.85%
ROA (Return on Assets):4.39%
P/E (trailing):22.60
P/E (forward):13.77
Price / Book:2.92
PEG Ratio:1.73
52-Week Change:+20.96%
S&P 500 change, 52 weeks:+11.37%

Historical Evolution (Last 4 Years)

Income Statement

Balance Sheet

Cash Flow

EPS and Earnings Per Share

Key EPS Metrics

EPS Trailing (TTM):$3.65

Diluted EPS for the last 12 months: the four quarters ended Sep 26, 2026, from the accounts filed with the SEC on Nov 3, 2026. The P/E is the price divided by that EPS.

EPS Forward (Est.):$5.99
P/E (forward):13.77
PEG Ratio:1.73

Growth and Margins

Earnings Growth YoY:-
Quarterly Earnings Growth YoY:-
Rev Growth YoY:-
Net Margin:-
Gross Margin:-
EBITDA Margin:-

Per Share

Revenue Per Share:$116.77
Cash Per Share:-
Book Value:$28.21

Cash Flows (TTM)

Free Cash Flow:446.00M
Operating Cash Flow:700.00M
EBITDA:1.08B
Total Revenue (TTM):13.60B
Net Income (TTM):403.00M
Fiscal Year (Last):-

EPS Surprise History - Last 4 Quarters

Actual vs. Analyst Estimates · Green = beat expectations · Red = missed

Quarter Period Actual EPS Estimated EPS Difference Surprise % Currency

Ownership Structure

Ownership Distribution

% Insiders:-
% Institutional:-
% Inst. (of Float):-
No. of Institutions:-
Visual distribution
InsidersInstitutionalFree Float

Shares & Short Interest

Shares Outstanding:111,446,542
Float (free shares):91,710,474
Short interest (shares):9,005,470
Short % of float:-
Short Ratio (days to cover):6.93
Short interest, prior month:-
Short Interest Date:-

Governance Score (1=Best, 10=Worst)

Overall risk:-
Audit Risk:-
Board risk:-
Compensation Risk:-
Shareholder rights risk:-

Top Institutional Holders

Position Change: ▲ Increased · ▼ Reduced · = Unchanged

Organization Report Date % Shares No. Shares Value (USD) Change %

Top Mutual Funds

Position Change: ▲ Increased ▼ Decreased = Unchanged

Fund Report Date % Shares No. Shares Value (USD) Change %

Recent Insider Trades

Executive / Insider Title Date Action Shares

Options Chain

CALLS

StrikeLastBidAskVol.O.I.IV

PUTS

StrikeLastBidAskVol.O.I.IV

Henry Schein, Inc. (HSIC) SEC filings: 10-K, 10-Q and 8-K

Direct links to financial reports filed with the SEC.

Type Date Official link
8-K2026-11-03View filing ↗
8-K2026-10-08View filing ↗
8-K2026-09-22View filing ↗
8-K2026-08-04View filing ↗
8-K2026-07-30View filing ↗
11-K2026-06-18View filing ↗
SD2026-05-29View filing ↗
8-K2026-05-22View filing ↗
DEFA14A2026-05-12View filing ↗
10-Q2026-05-05View filing ↗

Company and Executive Profile

Henry Schein, Inc. provides health care products and services to office-based dental and medical practitioners worldwide. It operates through Global Distribution and Value-Added Services; Global Specialty Products; and Global Technology segments. The Global Distribution and Value-Added Services segment distributes infection-control products, handpieces, preventatives, impression materials, composites, anesthetics, teeth, gypsum, acrylics, articulators, abrasives, PPE products, branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, dental chairs, delivery units and lights, digital dental laboratories, X-ray supplies and equipment, and high-tech and digital restoration equipment, as well as provides equipment repair services, financial services on a non-recourse basis, continuing education services for practitioners, consulting, and other services. It also markets and sells a portfolio of consumable merchandise under its own corporate brand. The Global Specialty Products segment engage in manufacturing, marketing, and sales of dental implant and biomaterial products; and endodontic, orthodontic and orthopedic products, and other health care-related products and services. The Global Technology segment is involved in the development and distribution of practice management software, e-services, and other products which are distributed to health care providers. The company serves dental practices, laboratories, physician practices, and ambulatory surgery centers, as well as government, institutional health care clinics, home health providers, and other alternate care clinics. It has a strategic partnership with GoTu Technology to help dental practices address ongoing staffing challenges. Henry Schein, Inc. was founded in 1932 and is headquartered in Melville, New York.

General Information

Headquarters:United States
City:Melville
Employees:25,000
Sector:Healthcare
Industry:Medical Distribution
Website:-

Key Executives

NameTitleAgeTotal pay
Mr. Ronald N. SouthSenior VP & CFO631.18M
Mr. Andrea AlbertiniChief Executive Officer of Global Distribution & Technology551.77M
Mr. Frederick M. LoweryCEO & Director54-
Ms. Olga TimoshkinaVP of Corporate Finance & Chief Accounting Officer--
Mr. Christopher PendergastSenior VP & CTO62-
Mr. Graham StanleyVP of Investor Relations & Strategic Finance Project Officer--
Ms. Kelly Murphy J.D.Senior VP & General Counsel44-
Timothy VassilakosVice President of Global Corporate Communications--

You have seen the engine room

A free account saves your simulator portfolios, your personal portfolio and your Academy progress, synced across devices. And, if you switch it on, the email alert the same day an insider buys stock in their own company.

No card. No spam.

Henry Schein, Inc. (HSIC): Quantitative Analysis

Henry Schein, Inc. (HSIC) — Healthcare — Medical Distribution. HSIC is in the S&P 500 today. Model factor scores and market data, recalculated every trading day.

So far in 2026, HSIC has returned +9.2% against +11.4% for the S&P 500 (SPY): total return, dividends included on both sides, from Dec 31, 2025 to Nov 3, 2026.

HSIC ranks 90 of 461 on today's multifactor score, and 8 of the 55 Healthcare companies that score. Its strongest factor is momentum (Z 0.99, ranked 67 of 494); its weakest is quality (Z -0.50, ranked 388 of 468). Each factor ranks only the companies with data for it, and the multifactor score only those with all four: that is why the totals differ.

Factor scores

The Z-Score is how many standard deviations the company sits from the index average: 0 is average, positive is better than average, negative is worse.

FactorZ-ScoreRank
Multifactor0.25490 of 461 ↑4
Momentum0.98967 of 494 ↓4
Value0.56989 of 489
Quality-0.497388 of 468
Growth-0.045182 of 489

Market data

MetricValue
Price$82.50
Market Cap9.19B
P/E22.60
Revenue (last 12 months)13.60B
Price / book2.92
Book value per share$28.21
52-week range$68.00 – $92.18
Dividend yield0.00%
Beta0.86
Average volume1,171,628
Shares outstanding111.45M
Short interest (% of float)9.79% (as of Oct 15, 2026)

When does HSIC report earnings? 12 of its last 12, before the open →

What are HSIC insiders doing? 70 transactions filed with the SEC, of them 1 buy and 8 sells, the last one on Sep 8, 2026 →

HSIC latest SEC filings

Filing dates on EDGAR, the SEC's public registry. All HSIC filings on EDGAR.

Guides: How to read a Quant500 company page · What the S&P 500 is · P/E ratio explained · 10-K, 10-Q and 8-K · all guides

Frequently asked questions about Henry Schein (HSIC)

When does Henry Schein report earnings?

Henry Schein has no announced date in the Nasdaq public calendar checked (Nov 3, 2026 to Dec 7, 2026). Of its last 12 earnings announcements: 12 before the open (SEC filings through Nov 3, 2026). HSIC earnings dates and times, quarter by quarter →

What is Henry Schein's P/E ratio?

Henry Schein's P/E (price over earnings per share for the last twelve months) is 22.6 at the Nov 3, 2026 close. That EPS is the 12-month diluted figure from the SEC, the four quarters ended Sep 26, 2026. The median of the 54 Healthcare companies with a P/E is 30.5, and the S&P 500's, 23.5: Henry Schein is below its sector median. Healthcare stocks, company by company →

Where does Henry Schein rank on Quant500?

In the Nov 3, 2026 multi-factor ranking, Henry Schein ranks 90 of 461, and 8 of the 55 Healthcare companies that score. The ranking orders S&P 500 companies by the average of four factors (momentum, value, quality and growth) and is recalculated every trading day. It is a model output, not investment advice. The full ranking → How it is calculated →

Have Henry Schein insiders bought or sold shares?

The latest open-market purchase of Henry Schein shares filed with the SEC (Form 4) was on May 11, 2026, by a director, for $692k. The latest sale was on Mar 19, 2026, by an officer, for $99k. In total, from August 2025 through Nov 3, 2026: 1 purchase and 8 sales by directors, officers and large shareholders. All HSIC insider trades →

What sector is Henry Schein in, and which index?

Henry Schein is classified in the Healthcare sector (industry: Medical Distribution), per the data provider's classification (similar to GICS, not identical). It is in the S&P 500 today. It is one of the 59 S&P 500 companies in that sector. Healthcare stocks →

What is behind these numbers

The concepts on this page, explained from scratch in the Academy. Free, no account.

The whole Academy, course by course →

Data as of Nov 3, 2026. Source: point-in-time SEC fundamentals and closing prices. Method and formulas are on the home page.

The model portfolio, weekly in your inbox

Every Saturday, its week in one minute: how it went, the best and the worst, and which insiders bought with their own money. Plus, the day the model is rebuilt, which stocks come in and which go out. A simulation, not advice. At most one email a week, no ads, no account; one-click unsubscribe. Made by one person: Pol Gracia.

A model portfolio with simulated results, not a personalized recommendation. Your email is used for this only: privacy.

S&P 500 market gravity